Aurobindo Pharma Limited — Others, 29-01-2025: Action(s) taken or orders passed

Aurobindo Pharma has received two orders from the Deputy Commissioner (ST) STU-1 in Hyderabad for recovery of Compensation Cess refunded in May and June 2018. The total demand amounts to approximately ₹1.92 crore for May and ₹0.70 crore for June, including tax, interest, and penalties. The orders allege that the refunds sanctioned were erroneous due to the company's zero-rated supplies. Aurobindo intends to appeal these decisions. While there is no material impact on financials or operations, this situation could generate investor concern over potential liabilities and ongoing disputes, emphasizing the importance of monitoring regulatory compliance.